EcoR1 Capital, LLC, Director at Aktis Oncology, Inc. (AKTS), bought 2,222,222 shares at $18.00 ($40.0M) on 2026-01-12, disclosed to the SEC on 2026-01-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.00 | 144,443 | $2.6M | 6.5% |
| 2 | $18.00 | 2,077,779 | $37.4M | 93.5% |
| Total | $18.00 avg | 2,222,222 | $40.0M | 100% |
| Filing → |
| ADAP | SELL | 2025-07-30 | $13.2M | — | Filing → |
| ZYME | BUY | 2025-05-19 | $1.3M | — | Filing → |
| ITOS | BUY | 2025-05-16 | $51.0M | — | Filing → |